CA2604143C - Methodes de detection de cellules de carcinome thyroidien - Google Patents

Methodes de detection de cellules de carcinome thyroidien Download PDF

Info

Publication number
CA2604143C
CA2604143C CA2604143A CA2604143A CA2604143C CA 2604143 C CA2604143 C CA 2604143C CA 2604143 A CA2604143 A CA 2604143A CA 2604143 A CA2604143 A CA 2604143A CA 2604143 C CA2604143 C CA 2604143C
Authority
CA
Canada
Prior art keywords
lar
antibody
cells
thyroid
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2604143A
Other languages
English (en)
Other versions
CA2604143A1 (fr
Inventor
Hiroshi Yamamoto
Kazutake Tsujikawa
Yukiko Uchino
Noboru Konishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fuso Pharmaceutical Industries Ltd
Original Assignee
Fuso Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuso Pharmaceutical Industries Ltd filed Critical Fuso Pharmaceutical Industries Ltd
Priority claimed from CA002329776A external-priority patent/CA2329776C/fr
Publication of CA2604143A1 publication Critical patent/CA2604143A1/fr
Application granted granted Critical
Publication of CA2604143C publication Critical patent/CA2604143C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Landscapes

  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA2604143A 1998-06-08 1999-06-07 Methodes de detection de cellules de carcinome thyroidien Expired - Fee Related CA2604143C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JPPCT/JP1998/02542 1998-06-08
JP9802542 1998-06-08
CA002329776A CA2329776C (fr) 1998-06-08 1999-06-07 Anticorps contre une sous-unite de phosphatase lar

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002329776A Division CA2329776C (fr) 1998-06-08 1999-06-07 Anticorps contre une sous-unite de phosphatase lar

Publications (2)

Publication Number Publication Date
CA2604143A1 CA2604143A1 (fr) 1999-12-16
CA2604143C true CA2604143C (fr) 2011-11-01

Family

ID=38830304

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2604143A Expired - Fee Related CA2604143C (fr) 1998-06-08 1999-06-07 Methodes de detection de cellules de carcinome thyroidien

Country Status (1)

Country Link
CA (1) CA2604143C (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111208304B (zh) * 2020-01-20 2023-06-16 中国医学科学院北京协和医院 肿瘤来源IgG在甲状旁腺癌诊断和预后中的用途

Also Published As

Publication number Publication date
CA2604143A1 (fr) 1999-12-16

Similar Documents

Publication Publication Date Title
US6846912B1 (en) Antibody against LAR phosphatase subunit
KR100599454B1 (ko) 종양 억제자로 작용하는 ａｉｍ3의 신규 용도
US7083786B2 (en) MASP-2, a complement-fixing enzyme, and uses for it
US20080300208A1 (en) Isociatrate dehydrogenase and uses therof
KR20020073181A (ko) Ｌｉｖ-1 관련 단백질, 이를 코딩하는 폴리뉴클레오티드및 암의 치료를 위한 그의 용도
JP2007524622A (ja) 抗癌治療に対する腫瘍細胞の感受性を回復させてアポトーシスを誘導するための組成物及び方法
US9790503B2 (en) VHZ for diagnosis and treatment of cancer
WO2011100341A1 (fr) Nouvelle molécule de signalisation impliquée dans les lésions cutanées dues aux ultraviolets
CA2604143C (fr) Methodes de detection de cellules de carcinome thyroidien
JP2000050885A (ja) カテプシンに対する抗体およびそれらの利用
EP1097944B1 (fr) Anticorps specifique des domaines intracellulaires de la thyrosinephosphatase
EP1848742A1 (fr) Anticorps anti-prl-3 et leurs procédés d utilisation
WO2005071070A2 (fr) Substances dirigees contre une sequence specifique essentielle a l'activite catalytique de l'heparanase, et utilisations de celles-ci en tant qu'inhibiteurs de l'heparanase
JP4712692B2 (ja) 癌の診断と治療において有用な新規ポリペプチド
JP2023523145A (ja) リポ蛋白（ａ）に対するイソ型非依存性抗体
KR20150131655A (ko) Aimp2-dx2-34s 단백질 및 이의 제조방법
WO2005061704A1 (fr) Substance destinee a la prevention et au traitement du cancer
WO2006101273A1 (fr) Agent prophylactique et therapeutique contre le cancer
CA2362936A1 (fr) Proteine kinase activee par la caspase
MXPA05003673A (es) Composiciones, organismos y metodologias que emplean una cinasa humana novedosa.
JPWO2002057448A1 (ja) 新規ペプチド及びその活性
WO2009055498A2 (fr) Mig-7 en tant que cible anticancéreuse spécifique

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20160607